VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CGTX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CGTXCognition Therapeutics, Inc.
$1.07$79M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCGTXQuarterly Financials

Cognition Therapeutics, Inc. (CGTX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Cognition Therapeutics, Inc. (CGTX) quarterly income statement — complete revenue, gross profit & net income history

CGTX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold0061K0000058K00000000000
COGS % of Revenue--------------------
Gross Profit00-61K00000-58K00000000000
Gross Margin %--------------------
Gross Profit Growth %----100%---------------
Operating Expenses8.82M13.67M6.31M13.98M13.78M10.72M14.46M14.68M14.04M15.19M14.74M11.82M8.97M9.3M12.63M12.21M9.41M11.81M5.22M5.98M
OpEx % of Revenue--------------------
Selling, General & Admin2.7M2.52M2.6M2.5M2.99M2.57M3.07M3.1M3.49M3.59M3.08M3.32M3.54M2.86M4.36M3.12M2.9M6.24M1.55M1.09M
SG&A % of Revenue--------------------
Research & Development6.12M11.15M3.77M11.48M10.79M8.15M11.39M11.58M10.55M11.6M11.67M8.5M5.43M6.44M8.27M9.1M6.52M5.57M3.67M4.89M
R&D % of Revenue--------------------
Other Operating Expenses00-61K00000000000000000
Operating Income-8.82M-13.67M-6.38M-13.98M-13.78M-10.72M-14.46M-14.68M-14.1M-15.19M-14.74M-11.82M-8.97M-9.3M-12.63M-12.21M-9.41M-11.81M-5.22M-5.98M
Operating Margin %--------------------
Operating Income Growth %35.99%-27.49%55.92%4.77%2.32%29.4%1.91%-24.21%-57.16%-63.32%-16.79%3.24%4.67%21.24%-141.72%-104.09%-68.6%-186.6%--
EBITDA-8.82M-13.61M-6.31M-13.92M-13.73M-10.65M-14.39M-14.61M-14.04M-15.12M-14.68M-11.76M-8.91M-9.24M-12.56M-12.15M-9.36M-11.79M-5.2M-5.96M
EBITDA Margin %--------------------
EBITDA Growth %35.78%-27.77%56.13%4.75%2.24%29.56%1.96%-24.29%-57.57%-63.67%-16.83%3.27%4.75%21.6%-141.63%-103.93%-68.29%-187.72%--
D&A (Non-Cash Add-back)061K61K61K45K71K70K67K58K66K65K61K60K60K60K59K56K23K23K24K
EBIT0-3.34M-4.93M-6.73M-8.47M-7.84M-9.93M-7.03M-9.14M-8.13M-6.75M-4.72M-6.16M-5.17M-6.62M-5.87M-3.7M-7.34M-3.11M-1.13M
Net Interest Income5K-5K0-3K-5K-5K-3K-7K-10K-9K-2K-6K-10K-10K-2K-7K-9K1K0-357K
Interest Income000000000000000001K00
Interest Expense-5K5K03K5K5K3K7K10K9K2K6K10K10K2K7K9K00357K
Other Income/Expense010.33M1.45M7.24M5.29M2.88M4.53M7.64M4.95M7.05M8M7.09M2.8M4.12M6M6.34M5.7M4.47M2.11M4.49M
Pretax Income0-3.34M-4.93M-6.73M-8.48M-7.84M-9.94M-7.04M-9.15M-8.14M-6.75M-4.73M-6.17M-5.18M-6.63M-5.88M-3.71M-7.34M-3.11M-1.49M
Pretax Margin %--------------------
Income Tax000000000000000-125K125K000
Effective Tax Rate %-0%0%0%0%0%0%0%0%0%0%0%0%0%0%2.13%-3.37%0%0%0%
Net Income0-3.34M-4.93M-6.73M-8.48M-7.84M-9.94M-7.04M-9.15M-8.14M-6.75M-4.73M-6.17M-5.18M-6.63M-5.75M-3.84M-7.34M-3.11M-1.49M
Net Margin %--------------------
Net Income Growth %100%57.37%50.39%4.36%7.33%3.67%-47.24%-48.98%-48.27%-57.1%-1.87%17.84%-60.81%29.39%-113.02%-286.04%-1821.08%-292.88%--
Net Income (Continuing)0-3.34M-4.93M-6.73M-8.48M-7.84M-9.94M-7.04M-9.15M-8.14M-6.75M-4.73M-6.17M-5.18M-6.63M-5.75M-3.84M-7.34M-3.11M-1.49M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.05-0.04-0.06-0.11-0.14-0.17-0.25-0.18-0.27-0.26-0.22-0.16-0.120.38-0.03-0.25-0.17-0.35-0.15-0.07
EPS Growth %64.29%77.88%74.72%38.89%48.15%34.62%-13.64%-12.5%-125%-168.42%-711.81%36%29.41%208.57%81.93%-251.62%-1734.62%-292.38%--
EPS (Basic)-0.05-0.04-0.06-0.11-0.14-0.17-0.25-0.18-0.27-0.26-0.22-0.16-0.120.38-0.03-0.25-0.17-0.35-0.15-0.07
Diluted Shares Outstanding89.19M88.9M77.95M63.69M61.83M46.43M40.42M40.06M33.74M30.78M30.37M29.61M29.09M28.99M23.02M22.6M22.43M20.95M20.95M20.95M
Basic Shares Outstanding89.19M88.9M77.95M63.69M61.83M46.43M40.42M40.06M33.74M30.78M30.37M29.61M29.09M28.99M23.02M22.6M22.43M20.95M20.95M20.95M
Dividend Payout Ratio--------------------